Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Cancer for Phase II”

482 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 482 results

Not applicableStudy completedNCT03273374
What this trial is testing

Intraoperative Radiation Therapy for Resectable Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Adenocarcinoma
Gangnam Severance Hospital 42
Testing effectiveness (Phase 2)Ended earlyNCT01555489
What this trial is testing

Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca

Who this might be right for
Stage IV Pancreatic Cancer
Thomas Jefferson University 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05562297
What this trial is testing

Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Stage IBPancreatic Cancer, Stage IIAPancreatic Cancer, Stage IIB+1 more
Shanghai Zhongshan Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00025168
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Wake Forest University Health Sciences 20
Testing effectiveness (Phase 2)Study completedNCT04953962
What this trial is testing

Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Stage IV
CanBas Co. Ltd. 36
Testing effectiveness (Phase 2)Looking for participantsNCT06051851
What this trial is testing

Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 177
Testing effectiveness (Phase 2)Looking for participantsNCT06761027
What this trial is testing

MFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Fujian Provincial Hospital 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT05026905
What this trial is testing

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

Who this might be right for
Phase II, Open-label, Parallel 2-arm, Multi-center
National Health Research Institutes, Taiwan 66
Testing effectiveness (Phase 2)Study completedNCT02704156
What this trial is testing

SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Changhai Hospital 170
Early research (Phase 1)Ended earlyNCT02703571
What this trial is testing

Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors

Who this might be right for
Solid Tumors for Phase IbPancreatic Cancer for Phase IIColorectal Cancer for Phase II
Novartis Pharmaceuticals 95
Testing effectiveness (Phase 2)Study completedNCT01553019
What this trial is testing

Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Florida 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT03935893
What this trial is testing

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+7 more
Udai Kammula 20
Testing effectiveness (Phase 2)Looking for participantsNCT05132504
What this trial is testing

Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Baylor College of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT04385992
What this trial is testing

Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNET

Who this might be right for
Neuroendocrine Tumors
IRCCS San Raffaele 31
Testing effectiveness (Phase 2)Study completedNCT00365144
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine

Who this might be right for
Pancreatic Cancer
University of California, San Francisco 36
Testing effectiveness (Phase 2)Looking for participantsNCT06050317
What this trial is testing

Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Shandong Cancer Hospital and Institute 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07233850
What this trial is testing

A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers

Who this might be right for
Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Shenyang Sunshine Pharmaceutical Co., LTD. 300
Testing effectiveness (Phase 2)UnknownNCT05795920
What this trial is testing

Utidelone Injection Combined With Gemcitabine in First-line Chemotherapy for Unresectable Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 92
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Testing effectiveness (Phase 2)Study completedNCT02194829
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v6 and v7Stage IV Pancreatic Cancer AJCC v6 and v7+1 more
National Cancer Institute (NCI) 8
Load More Results